| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/LIV.13562 |
| P8608 | Fatcat ID | release_tvpxlbwt5bc7xg3ccr3j77uboq |
| P932 | PMC publication ID | 5836915 |
| P698 | PubMed publication ID | 28853202 |
| P50 | author | Cecília Rodrigues | Q30421070 |
| Rui E. Castro | Q43087499 | ||
| Hanns-Ulrich Marschall | Q59585339 | ||
| Michael Trauner | Q62560551 | ||
| Anders Thorell | Q87936011 | ||
| Michaela Mueller | Q88874032 | ||
| P2093 | author name string | Merima Herac | |
| Nicole Auer | |||
| P2860 | cites work | Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1 | Q22011167 |
| TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death | Q24298384 | ||
| CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells | Q24301679 | ||
| Roles of CHOP/GADD153 in endoplasmic reticulum stress | Q24302185 | ||
| Acetylation is indispensable for p53 activation | Q24313477 | ||
| Bile acids: regulation of apoptosis by ursodeoxycholic acid | Q24653969 | ||
| Exosomal miRNAs as cancer biomarkers and therapeutic targets | Q26738660 | ||
| Emerging functions of the unfolded protein response in immunity | Q26827965 | ||
| The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion | Q28117802 | ||
| Nonalcoholic fatty liver disease: a systematic review | Q28263139 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis | Q28510028 | ||
| p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis | Q28568391 | ||
| Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 | ||
| A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine | Q29547303 | ||
| Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis | Q29547575 | ||
| Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes | Q29615503 | ||
| Nonalcoholic fatty liver disease | Q29619354 | ||
| Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal | Q30757632 | ||
| Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals | Q33345339 | ||
| Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases | Q33723536 | ||
| Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. | Q34024266 | ||
| Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid | Q34212063 | ||
| Apoptosis: the nexus of liver injury and fibrosis. | Q35651666 | ||
| Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity | Q35672242 | ||
| Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation | Q35747483 | ||
| Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver | Q36335957 | ||
| Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice | Q36479005 | ||
| Mitochondrial stress: a bridge between mitochondrial dysfunction and metabolic diseases? | Q37880356 | ||
| The measurement and mechanism of lipid peroxidation in biological systems | Q37923154 | ||
| Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease | Q38072666 | ||
| The role of ER stress in lipid metabolism and lipotoxicity | Q38825911 | ||
| Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress | Q40088792 | ||
| Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis | Q40960591 | ||
| Protein synthesis by membrane-bound and free ribosomes of secretory and non-secretory tissues | Q41906977 | ||
| Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities | Q43552270 | ||
| Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice | Q44569549 | ||
| S-adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice☆ | Q44617752 | ||
| Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease | Q44934521 | ||
| Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis | Q45016055 | ||
| Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. | Q46373616 | ||
| Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease | Q46397581 | ||
| Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans | Q46637413 | ||
| Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. | Q51353878 | ||
| miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease | Q60895711 | ||
| Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis | Q79426743 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P304 | page(s) | 523-531 | |
| P577 | publication date | 2017-09-18 | |
| P1433 | published in | Liver International | Q15765078 |
| P1476 | title | Ursodeoxycholic acid: Effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients | |
| P478 | volume | 38 |
| Q91658037 | Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican-American Population of South Texas |
| Q90731281 | Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs |
| Q60047622 | Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome |
Search more.